Valuation: Cosmos Health Inc.

Market Cap 14.67M 12.85M 11.83M 10.98M 20.85M 1.4B 21.14M 142M 55.12M 687M 55.08M 53.87M 2.38B P/E 2026 *
27x
P/E 2027 * 3.86x
Enterprise Value 14.67M 12.85M 11.83M 10.98M 20.85M 1.4B 21.14M 142M 55.12M 687M 55.08M 53.87M 2.38B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.13x
Free-Float
65.92%
Yield 2026 *
-
Yield 2027 * -
1 day+3.74%
1 week+54.03%
Current month+54.03%
1 month+23.70%
3 months-4.63%
6 months-45.34%
Current year-42.87%
1 week 0.18
Extreme 0.175
0.31
1 month 0.16
Extreme 0.1616
0.31
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
1.32
3 years 0.16
Extreme 0.1616
3.42
5 years 0.16
Extreme 0.1616
150
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 2016-02-25
Director of Finance/CFO 44 2020-11-10
Chief Operating Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 59 2014-01-12
Chairman 60 2016-02-25
Director/Board Member 60 2016-11-17
Date Insider Type Main position Quantity % Market Cap.
06-15Buy

Chief Financial Officer

168,135 0.2708%
06-10Buy

Chief Executive Officer

218,447 0.3519%
06-09Buy

Chief Executive Officer

701,447 1.1299%
Change 5-day change 1-year change 3-year change Capi.($)
+3.74%+54.03%-36.14%-90.79% 14.67M
+2.55%+6.83%+9.77%+94.60% 91.82B
+1.66%+1.86%+44.36%+157.51% 55.63B
0.00%+0.71%-6.31%+241.82% 22.51B
-1.76%+1.76%-9.87%-23.67% 8.16B
-3.98%+1.78%-28.31%-32.96% 7.86B
-1.28%+5.32%-8.10%-27.73% 6.86B
+1.72%+3.01%+23.83%+38.04% 6.32B
+0.76%+2.79%-2.53%+23.61% 5.31B
-1.98%+3.77%-4.81%-7.46% 3.71B
Average +0.04%+7.51%-1.81%+37.30% 20.82B
Weighted average by Cap. +1.31%+2.30%+14.33%+108.49%

Financials

2026 *2027 *
Net sales 87.3M 76.46M 70.42M 65.37M 124M 8.33B 126M 843M 328M 4.09B 328M 321M 14.17B 111M 97.04M 89.38M 82.96M 158M 10.57B 160M 1.07B 416M 5.19B 416M 407M 17.99B
Net income - -
Net Debt - -
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
26-07-07 US$0.2861 +6.00% 52,371,915
26-07-06 US$0.2699 +13.83% 23,512,677
26-07-02 US$0.2371 +17.61% 18,865,848
26-07-01 US$0.2016 +9.15% 11,676,430
26-06-30 US$0.1847 +5.54% 40,581,107

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. COSM Stock